Master Protocol Trial Design for Efficient and Rational Evaluation of Novel Therapeutic Oncology Devices

Historically, the gold standard for evaluation of cancer therapeutics, including medical devices, has been the randomized clinical trial. Although high-quality clinical data are essential for safe and judicious use of therapeutic oncology devices, class II devices require only preclinical data for U...

Descripción completa

Detalles Bibliográficos
Autores principales: Bitterman, Danielle S, Cagney, Daniel N, Singer, Lisa, Nguyen, Paul L, Catalano, Paul J, Mak, Raymond H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073911/
https://www.ncbi.nlm.nih.gov/pubmed/31504680
http://dx.doi.org/10.1093/jnci/djz167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073911/
https://www.ncbi.nlm.nih.gov/pubmed/31504680
http://dx.doi.org/10.1093/jnci/djz167

Ejemplares similares